Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) EPS (Basic) (2018 - 2025)

Health Catalyst's EPS (Basic) history spans 8 years, with the latest figure at -$1.3 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 293.94% year-over-year to -$1.3; the TTM value through Dec 2025 reached -$2.56, down 122.61%, while the annual FY2025 figure was -$2.55, 121.74% down from the prior year.
  • EPS (Basic) reached -$1.3 in Q4 2025 per HCAT's latest filing, down from -$0.32 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.23 in Q2 2024 to a low of -$1.3 in Q4 2025.
  • Average EPS (Basic) over 5 years is -$0.58, with a median of -$0.58 recorded in 2023.
  • Peak YoY movement for EPS (Basic): surged 60.34% in 2024, then crashed 293.94% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.96 in 2021, then surged by 30.21% to -$0.67 in 2022, then rose by 22.39% to -$0.52 in 2023, then soared by 36.54% to -$0.33 in 2024, then plummeted by 293.94% to -$1.3 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's EPS (Basic) are -$1.3 (Q4 2025), -$0.32 (Q3 2025), and -$0.59 (Q2 2025).